Stephen C. Lazarus MD
Asthma & COPD, Critical Care Medicine, Pleural Disease
Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
505 Parnassus Ave1087 MSan Francisco, CA 94143
Phone+1 415-353-2961
Fax+1 415-476-5712
Dr. Lazarus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1975 - 1977- University of California (San Francisco)Residency, Internal Medicine, 1973 - 1975
- University of California (San Francisco)Internship, Internal Medicine, 1972 - 1973
University of California, Irvine, School of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease Start of enrollment: 2005 Mar 01
- Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease Start of enrollment: 2006 Mar 01
- Simvastatin Therapy for Moderate and Severe COPD Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsβ-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.David C LaFon, Erika S Helgeson, Sarah Lindberg, Helen Voelker, Surya P Bhatt
JAMA Network Open. 2024-05-01 - 5 citationsLongitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.William McKleroy, Tracie Shing, Wayne H Anderson, Mehrdad Arjomandi, Hira Anees Awan
JAMA. 2023-08-01 - 3 citationsLung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.Trisha M Parekh, Erika S Helgeson, John Connett, Helen Voelker, Sharon X Ling
Annals of the American Thoracic Society. 2022-10-01
Press Mentions
Mometasone, Tiotropium Show No Preferred Asthma Benefit in SIENA TrialMay 19th, 2019
Eosinophil Levels Affect Glucocorticoid Response in Mild, Persistent AsthmaMay 19th, 2019
Lansoprazole for Children with Poorly Controlled AsthmaA Randomized Controlled TrialJanuary 25th, 2012
Grant Support
- SPIROMICSNational Heart, Lung & Blood Institute2009–Present
- AsthmaNetNational Heart, Lung & Blood Institute2009–Present
- COPD Clinical ResearchNetworkNational Heart, Lung & Blood Institute2006–Present
- Asthma Clinical Research NetworkNational Heart, Lung & Blood Institute2003–2011
- COPD Clinical Research NetworkNational Heart, Lung, And Blood Institute2003–2006
- Non-Immunologic Contact Urticaria And MAST CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1989
- Non-Immunologic Contact Urticaria &Mast CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1987–1988
- Regulation Of Tracheal Secretory Cells: Role Of CAMPNational Heart, Lung, And Blood Institute1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
